Kindstar Globalgene Technology, Inc. (Kindstar) disclosed that it repurchased 15,500 ordinary shares on 26 June 2026 via the Hong Kong Stock Exchange at prices between HK$0.96 and HK$0.97 per share, spending approximately HK$0.01 million in aggregate. The shares will be held as treasury stock. No shares were cancelled.

Following the transaction, Kindstar’s outstanding share count (excluding treasury shares) decreased by 0.0015% to 1,033,984,640 shares, while treasury shares rose to 7,342,000. Total issued shares remained unchanged at 1,041,326,640.

The purchase forms part of the HK$ share-repurchase mandate approved on 5 June 2026, which authorises the company to buy back up to 103.43 million shares. Including the latest deal, Kindstar has repurchased 278,000 shares under this mandate—equivalent to 0.03% of the issued share base at the date the mandate was granted—leaving capacity for a further 103.15 million shares.

Pursuant to Hong Kong listing rules, Kindstar is restricted from issuing new shares or disposing of treasury shares until 26 July 2026.